BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24856188)

  • 1. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.
    Stenman G; Persson F; Andersson MK
    Oral Oncol; 2014 Aug; 50(8):683-90. PubMed ID: 24856188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
    Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
    J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and molecular profile of salivary gland cancer in children.
    Locati LD; Collini P; Imbimbo M; Barisella M; Testi A; Licitra LF; Löning T; Tiemann K; Quattrone P; Bimbatti E; Chiaravalli S; Casanova M; Tamborini E; Carta R; Gasparini P; Guzzo M; Massimino M; Ferrari A
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28139061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy.
    Andersson MK; Stenman G
    Oral Oncol; 2016 Jun; 57():63-9. PubMed ID: 27101980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.
    Andersson MK; Åman P; Stenman G
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
    Stenman G
    Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland cancers: biology and molecular targets for therapy.
    Bell D; Hanna EY
    Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.
    Rito M; Fonseca I
    Pathobiology; 2018; 85(1-2):85-95. PubMed ID: 28930752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation-associated salivary gland tumors: a review and update.
    Weinreb I
    Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Gland Cancers: Biology and Systemic Therapy.
    Goyal G; Mehdi SA; Ganti AK
    Oncology (Williston Park); 2015 Oct; 29(10):773-80. PubMed ID: 26470903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoid cystic carcinoma: emerging role of translocations and gene fusions.
    Wysocki PT; Izumchenko E; Meir J; Ha PK; Sidransky D; Brait M
    Oncotarget; 2016 Oct; 7(40):66239-66254. PubMed ID: 27533466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck.
    Shibata E; Morita KI; Kayamori K; Tange S; Shibata H; Harazono Y; Michi Y; Ikeda T; Harada H; Imoto I; Yoda T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Oct; 132(4):426-433. PubMed ID: 34413003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.
    Fehr A; Kovács A; Löning T; Frierson H; van den Oord J; Stenman G
    J Pathol; 2011 Jul; 224(3):322-7. PubMed ID: 21618541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
    Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
    Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland carcinoma: Towards a more personalised approach.
    Rached L; Saleh K; Casiraghi O; Even C
    Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.